• Archer-Daniels-Midland Company has already reported its first-quarter 2026 results, posting sales of US$20,490 million and net income of US$298 million, while its board declared a cash dividend of US$0.52 per share, marking the 378th consecutive quarterly payout and 53 years of consecutive dividend increases.
• Behind the modest year-on-year increases in revenue and earnings, adjusted profitability and higher full-year EPS guidance underline how improved crushing and ethanol margins, tax credits, and cost-saving plans are reshaping ADM’s mix of earnings drivers.
• We’ll now examine how ADM’s raised full-year earnings guidance could influence its existing investment narrative built around policy support and execution risk.

This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.

Archer-Daniels-Midland Investment Narrative Recap

To own ADM, you have to believe its mix of agricultural processing and higher value ingredients can convert policy support for biofuels and nutrition trends into steadier earnings, despite recent earnings volatility and low margins. Q1’s raised EPS guidance and stronger crushing and ethanol margins reinforce that policy clarity remains the key near term catalyst, while the biggest risk is that future policy shifts or commodity swings could quickly unsettle those improved margins and reignite earnings uncertainty.

The most relevant development here is ADM lifting its 2026 adjusted EPS guidance to US$4.15 to US$4.70, helped by better crushing and ethanol margins, tax credits, and cost savings. This directly speaks to whether ADM can offset pressure in Ag Services & Oilseeds and Carbohydrate Solutions through higher value-added areas like Biosolutions and Nutrition, and whether current policy support and execution on its cost program can meaningfully reduce the earnings volatility that has worried investors.

Yet beneath stronger guidance and a long dividend streak, investors should be aware that earnings still rely heavily on policy sensitive biofuel margins and...

Archer-Daniels-Midland's narrative projects $91.8 billion revenue and $2.1 billion earnings by 2029.

Uncover how Archer-Daniels-Midland's forecasts yield a $64.91 fair value, a 16% downside to its current price.

Exploring Other Perspectives

Some of the most pessimistic analysts were assuming flat revenues around US$82.6 billion and earnings of roughly US$2.1 billion by 2029, so this Q1 guidance lift and focus on crush and ethanol margins may challenge their view that cost savings and new platforms like biosolutions will not move the needle, and it is worth asking whether those darker assumptions still hold up in light of the latest numbers.

Explore 5 other fair value estimates on Archer-Daniels-Midland - why the stock might be worth as much as 56% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Archer-Daniels-Midland research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Archer-Daniels-Midland research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Archer-Daniels-Midland's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• Find 51 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.